James M. McCabe, MD
Please call to schedule an appointment with this provider.
James M. McCabe, MD
Medical Specialties
- Interventional cardiology
- Telehealth services
Top Conditions & Symptoms
- Aortic valve stenosis and regurgitation
- Mitral valve stenosis and regurgitation
- Tricuspid valve stenosis and regurgitation
- Coronary artery disease
Top Procedures & Treatments
- Transcatheter aortic valve replacement (TAVR)
- Transcatheter mitral valve repair (TMVR)
- Mitral valve repair (mitraclip)
- Tricuspid valve repair (tricuspid clip)
Locations
Heart Institute at UW Medical Center – Montlake
About James M. McCabe
Dr. James (Jamie) McCabe grew up in Boston, Massachusetts, graduated magna cum laude from Bowdoin College and received his medical degree from Yale University. He has completed 10 years of post-medical school training including internal medicine training and general cardiology fellowship at University of California, San Francisco (UCSF) and interventional cardiology fellowship as well as an advanced interventional fellowship in structural and peripheral treatments at Brigham and Women's Hospital / Harvard Medical School. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology.
Dr. McCabe joined the University of Washington Medical Center in 2013. He became medical director of the Cardiac Cath Labs in 2015 and subsequently was named Chief of Interventional Cardiology for the UW System in 2020. His clinical practice leverages his knowledge and experience in clinical cardiovascular medicine and complex coronary and valvular heart interventions. Dr. McCabe is an international leader in structural heart interventions including repair or replacement of all heart valves using catheter-based methods. He also treats all forms of coronary artery blockage and cardiogenic shock. He is an internationally recognized clinician educator and investigator in transcatheter therapies for valvular heart disease. His research interests focus on quality and performance metrics for cardiovascular procedures and novel transcatheter therapies to address unmet needs in the structural heart space. He has been the site principal investigator for dozens of clinical trials and has authored more than 100 original manuscripts and multiple book chapters related to his work. He lectures frequently at national and international meetings including at Transcatheter Cardiovascular Therapeutics (TCT), Trancatheter Valve Therapeutics (TVT), American College of Cardiology (ACC) and Society for Cardiac Angiography and Intervention (SCAI), amongst others. He has also been asked to perform live televised procedures for national and international audiences across multiple continents. He has been recognized as an Emerging Leader in Medicine by SCAI and the ACC, named one of three finalists for the Linnemeier Award, and voted a “Top Doc” in cardiology multiple years in a row by Seattle Magazine and Seattle Met Magazine.
Education and Training
-
Brigham and Women's HospitalFellowship, 2013, Interventional CardiologyUniversity of California, San FranciscoFellowship, 2011, Cardiovascular MedicineUCSF - Dept. of MedicineResidency, 2007, Internal MedicineUCSF - Dept. of MedicineInternship, 2005, Internal MedicineYale University School of MedicineMedical education, 2004UCSF